| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
|
J Am Coll Cardiol
|
2012
|
3.36
|
|
2
|
Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study.
|
J Am Coll Cardiol
|
2012
|
3.18
|
|
3
|
Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
|
J Am Coll Cardiol
|
2012
|
2.89
|
|
4
|
Left atrial appendage: an underrecognized trigger site of atrial fibrillation.
|
Circulation
|
2010
|
2.56
|
|
5
|
Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study.
|
Heart Rhythm
|
2009
|
2.30
|
|
6
|
Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy.
|
J Am Coll Cardiol
|
2012
|
2.04
|
|
7
|
Outcomes of atrioesophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting.
|
J Cardiovasc Electrophysiol
|
2014
|
2.02
|
|
8
|
Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors.
|
Heart Rhythm
|
2011
|
2.01
|
|
9
|
The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation.
|
J Am Coll Cardiol
|
2010
|
1.89
|
|
10
|
General anesthesia reduces the prevalence of pulmonary vein reconnection during repeat ablation when compared with conscious sedation: results from a randomized study.
|
Heart Rhythm
|
2010
|
1.79
|
|
11
|
Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
|
Circulation
|
2010
|
1.64
|
|
12
|
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation.
|
Europace
|
2011
|
1.64
|
|
13
|
Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experience.
|
J Cardiovasc Electrophysiol
|
2011
|
1.63
|
|
14
|
Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes.
|
J Cardiovasc Electrophysiol
|
2012
|
1.55
|
|
15
|
Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devices.
|
Heart Rhythm
|
2011
|
1.52
|
|
16
|
Administration of isoproterenol and adenosine to guide supplemental ablation after pulmonary vein antrum isolation.
|
J Cardiovasc Electrophysiol
|
2013
|
1.50
|
|
17
|
Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (APPROVAL).
|
Circulation
|
2013
|
1.48
|
|
18
|
Ablation of perimitral flutter following catheter ablation of atrial fibrillation: impact on outcomes from a randomized study (PROPOSE).
|
J Cardiovasc Electrophysiol
|
2011
|
1.44
|
|
19
|
The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females.
|
Europace
|
2010
|
1.43
|
|
20
|
Long-term outcome of catheter ablation in atrial fibrillation patients with coexistent metabolic syndrome and obstructive sleep apnea: impact of repeat procedures versus lifestyle changes.
|
J Cardiovasc Electrophysiol
|
2014
|
1.41
|
|
21
|
Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
|
Circ Arrhythm Electrophysiol
|
2011
|
1.35
|
|
22
|
Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis.
|
Circ Arrhythm Electrophysiol
|
2012
|
1.31
|
|
23
|
Worldwide experience with the robotic navigation system in catheter ablation of atrial fibrillation: methodology, efficacy and safety.
|
J Cardiovasc Electrophysiol
|
2012
|
1.28
|
|
24
|
Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.27
|
|
25
|
Ablation of atrial fibrillation utilizing robotic catheter navigation in comparison to manual navigation and ablation: single-center experience.
|
J Cardiovasc Electrophysiol
|
2009
|
1.19
|
|
26
|
Outcomes and complications of catheter ablation for atrial fibrillation in females.
|
Heart Rhythm
|
2009
|
1.09
|
|
27
|
Endo-epicardial ablation of ventricular arrhythmias in the left ventricle with the Remote Magnetic Navigation System and the 3.5-mm open irrigated magnetic catheter: results from a large single-center case-control series.
|
Heart Rhythm
|
2010
|
0.99
|
|
28
|
Examining the safety of amiodarone.
|
Expert Opin Drug Saf
|
2012
|
0.98
|
|
29
|
Positioning of left ventricular pacing lead guided by intracardiac echocardiography with vector velocity imaging during cardiac resynchronization therapy procedure.
|
J Cardiovasc Electrophysiol
|
2011
|
0.90
|
|
30
|
Novel association of polymorphic genetic variants with predictors of outcome of catheter ablation in atrial fibrillation: new directions from a prospective study (DECAF).
|
J Interv Card Electrophysiol
|
2016
|
0.90
|
|
31
|
Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival.
|
J Cardiovasc Electrophysiol
|
2014
|
0.88
|
|
32
|
Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis.
|
J Interv Card Electrophysiol
|
2011
|
0.87
|
|
33
|
Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility.
|
Heart Rhythm
|
2010
|
0.87
|
|
34
|
Long-term functional and neurocognitive recovery in patients who had an acute cerebrovascular event secondary to catheter ablation for atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2009
|
0.86
|
|
35
|
Omega-3 polyunsaturated Fatty Acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation.
|
Indian Pacing Electrophysiol J
|
2009
|
0.81
|
|
36
|
Locating the right phrenic nerve by imaging the right pericardiophrenic artery with computerized tomographic angiography: implications for balloon-based procedures.
|
Heart Rhythm
|
2010
|
0.79
|
|
37
|
Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation.
|
Heart Rhythm
|
2011
|
0.78
|
|
38
|
Dilator method and needle method for atrial transseptal puncture: a retrospective study from a cohort of 4443 patients.
|
Europace
|
2012
|
0.78
|
|
39
|
Baseline B-type natriuretic peptide: a gender-specific predictor of procedure-outcome in atrial fibrillation patients undergoing catheter ablation.
|
J Cardiovasc Electrophysiol
|
2011
|
0.78
|
|
40
|
Catheter ablation of atrial fibrillation in patients with mechanical mitral valve: long-term outcome of single procedure of pulmonary vein antrum isolation with or without nonpulmonary vein trigger ablation.
|
J Cardiovasc Electrophysiol
|
2014
|
0.78
|
|
41
|
Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.77
|
|
42
|
Pulmonary vein antrum isolation, atrioventricular junction ablation, and antiarrhythmic drugs combined with direct current cardioversion: survival rates at 7 years follow-up.
|
J Interv Card Electrophysiol
|
2009
|
0.77
|
|
43
|
Identifying the relationship between the non-PV triggers and the critical CFAE sites post-PVAI to curtail the extent of atrial ablation in longstanding persistent AF.
|
J Cardiovasc Electrophysiol
|
2011
|
0.76
|
|
44
|
Variant rs2200733 on chromosome 4q25 confers increased risk of atrial fibrillation: evidence from a meta-analysis.
|
J Cardiovasc Electrophysiol
|
2012
|
0.76
|
|
45
|
Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling.
|
J Cardiovasc Electrophysiol
|
2013
|
0.75
|
|
46
|
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer.
|
Invest New Drugs
|
2015
|
0.75
|
|
47
|
Reply: To PMID 22464257.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
48
|
Reply: Will LAA Isolation Increase Thrombosis and Stroke When Treating Persistent and Long-Standing Persistent AF?
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
49
|
Reply: A Prima Vista Ablation of Ventricular Tachycardia: Should We Abandon the Mapping of VT?
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
50
|
Safety and effectiveness of transvenous lead extraction in octogenarians.
|
J Cardiovasc Electrophysiol
|
2012
|
0.75
|
|
51
|
Reply: Factors Affecting Outcomes in Left Atrial Appendage Isolation by Catheter Ablation.
|
J Am Coll Cardiol
|
2017
|
0.75
|